Altogether, these results demonstrate that NLRP7-mediated NF-κB activation is mainly operating in non-tumor cells, which may be related to the lack of expression of NLRP7 inflammasome effectors in JEG-3 cells. This evidence concerns the gene NFKB1 and neoplasm.